Prostate cancer (PCa) is the second most prevalent malignant neoplasm among men globally, with its incidence rising significantly in China and Eastern European countries [1]. In recent years, multiparametric magnetic resonance imaging (mp-MRI), which includes T2-weighted imaging (T2WI), diffusion-weighted imaging (DWI), and dynamic contrast-enhanced imaging (DCE), has increasingly played a significant role in the non-invasive diagnosis of PCa [2]. To standardize MRI scan parameters and improve i…